We are dedicated to SXSW's vision of community-driven innovation. We’re proud to support several of our #clients who submitted proposals for panels at #SXSW2025. Help bring vital scientific perspectives to the forefront of the healthcare industry by voting on SXSW’s #PanelPicker through August 18th. Vote now: https://bit.ly/4dbTHmj Aphaia Pharma & Skye Bioscience Inc.: https://lnkd.in/gvqjGNf5 Y-mAbs Therapeutics, Inc.: https://lnkd.in/gbuUvP_d? Praxis Precision Medicines, Inc. & Alto Neuroscience: https://lnkd.in/gCxXWh2V ? ProFound Therapeutics & Quotient Therapeutics: https://lnkd.in/gSj5259D ? MindMed: https://lnkd.in/gYZuXyHm Lumos Pharma: https://lnkd.in/eXafTQjC
LifeSci Communications
公共关系和沟通服务
New York,New York 4,443 位关注者
Global communications and marketing agency focused in life science and medical technology.
关于我们
LifeSci Communications is a global communications and marketing agency focused in life science and medical technology. We create strategic custom programs implemented over months and years that evolve as your company grows to maintain your audience’s attention as well as your company’s leadership among peers. Our approach integrates capabilities in public relations, social and digital media and marketing communications. Interested in learning more? Click here: https://lifescicommunications.com/
- 网站
-
https://lifescicommunications.com/
LifeSci Communications的外部链接
- 所属行业
- 公共关系和沟通服务
- 规模
- 51-200 人
- 总部
- New York,New York
- 类型
- 私人持股
- 创立
- 2017
- 领域
- Public Relations、Healthcare、Marketing、Corporate Communications、Life Sciences、Biotech、MedTech、Social Media和Digital Media
地点
LifeSci Communications员工
动态
-
?? We are thrilled to celebrate our incredible clients, Cour Pharmaceuticals Development Co., Inc. and ProFound Therapeutics, for being named to the prestigious #Fierce15 list for 2024! We are honored to be part of your journey and can't wait to see the groundbreaking advancements you'll continue to bring to the world. Here's to many more milestones and successes! Check out the full list here: https://bit.ly/46CeUTS
Introducing Fierce Biotech's 2024 Fierce 15
fiercebiotech.com
-
Fatalities are an unfortunate reality of clinical trials. How can companies best protect themselves??Our crisis communications expert and media relations leader Drew Levinson is sharing best practices via real-life examples in BioSpace: https://lnkd.in/gNexkZ3b.??
Navigating Deaths During Clinical Trials
biospace.com
-
In case you missed it, we hosted two panels at the BIO International Convention! We heard from industry experts on breakthrough innovations transforming the #biotech industry. Thank?you to all moderators and?panelists for such an engaging discussion! Find panel recordings below:? Challenging Biotech’s One-Track Mind When it Comes to Neuropsychiatric Drug Innovation:?https://lnkd.in/evbMn59w What’s Nex-T: Innovator Roundtable on T Cell Therapies in Oncology:?https://lnkd.in/e9nxBWAy?
-
Our client, ProFound Therapeutics, was recently featured in STAT showcasing their first R&D collaboration with Flagship Pioneering and Pfizer in #obesity. Check it out here:?https://lnkd.in/eMu7h7mh
What do Parkinson's and obesity have in common?
https://www.statnews.com
-
Our work on Nanobiotix's corporate website earned a Web Excellence Award—a recognition for outstanding achievement in web design and experience. We're honored that the Nanobiotix team trusted us to showcase their unique physics-based approach as they embark on their next phase of growth. See the site: www.nanobiotix.com
-
Exciting news! Our team won a Web Excellence Award for creating and developing Bitterroot Bio's corporate website. This achievement is the result of inspiring collaboration with the entire Bitterroot team. Check out Bitterroot's site: www.brbio.com
-
Six CAR-T therapies have been approved by the FDA over the last six years to treat various types of #BloodCancers, but how are innovators navigating the challenges of the space? Learn from experts at our #BIO2024 panel moderated by Fierce Pharma and Fierce Biotech's Ruojing (Angus) Liu:?https://lnkd.in/e9nxBWAy
-
A recent study forecasts that half of the global population will experience a?#MentalHealth disorder in their lifetime. Yet current treatments fall short for?up to one-third of patients. Learn how experts plan to tackle the next wave of innovation in drug development at our #BIO2024 panel, moderated by?Heather McKenzie,?BioSpace’s Senior?Editor:? https://lnkd.in/evbMn59w??
-
BioSpace's Heather McKenzie is headed to #BIO24 on June 4th to host a panel discussion organized by LifeSci Communications on closing the gaps in neuropsychiatric drug development. We want to hear from you!
此处无法显示此内容
在领英 APP 中访问此内容等